Connecting to SEC EDGAR… PricingSign in
← All filings
Protara Therapeutics, Inc.TARA · Nov 6, 8:05 AM ET

Protara to acquire TARA-002 manufacturing assets for $8.75 million

Protara reported a third-quarter 2026 net loss of $21.7 million and an asset purchase agreement with Novex Innovations for TARA-002 manufacturing assets for $8.75 million.

AI-generated summary, checked against the filing. Can contain errors: read the original filing ↗. Not investment advice.